Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death.

about

Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death.

Item

http://www.wikidata.org/entity/Q38618204

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Contribution of serum FGF21 le ...... dysfunction and cardiac death.

@en

type

Item

label

Contribution of serum FGF21 le ...... dysfunction and cardiac death.

@en

prefLabel

Contribution of serum FGF21 le ...... dysfunction and cardiac death.

@en

P1476

Contribution of serum FGF21 le ...... dysfunction and cardiac death

@en

P2093

Qin Xiong

http://www.w3.org/2001/XMLSchema#string

Weiping Jia

http://www.w3.org/2001/XMLSchema#string

Xiaojing Ma

http://www.w3.org/2001/XMLSchema#string

Xiaoping Pan

http://www.w3.org/2001/XMLSchema#string

Xueli Zhang

http://www.w3.org/2001/XMLSchema#string

Yiting Xu

http://www.w3.org/2001/XMLSchema#string

Yun Shen

http://www.w3.org/2001/XMLSchema#string

Zhigang Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Projections of global mortality and burden of disease from 2002 to 2030

Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk

Standards of medical care in diabetes--2010.

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension.

Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients

Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.

Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice.

Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease

Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction.

Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome.

P2888

s12933-017-0588-5

P304

106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12933-017-0588-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yuqian Bao

P577

2017-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091239451

http://www.w3.org/2001/XMLSchema#string

P698

28821258

http://www.w3.org/2001/XMLSchema#string

P932

5562996

http://www.w3.org/2001/XMLSchema#string